C5a受体颉颃剂及其在动物疾病模型治疗中的研究进展

Abstract

Abstract: As a key part of the complement system in human and animal body, C5a receptor combined with C5a has been considered to mediate numerous biological processes and be involved in the pathology of numerous inflammatory diseases, such as ischemia-reperfusion injury, acute lung injury, sepsis, rheumatoid arthritis and glomerular nephritis．Therefore, current studies focus on how to block C5a receptor and dampen the inflammatory reaction. This review provides a brief overview of the current development of C5a receptor antagonists and their treatment in animal disease model.

Key words: C5a; C5a receptor; antagonists; complement; treatment

ZHANG Ze-ying, LIU Dong-xu. Research Progress on C5a Receptor Antagonists and their Treatment in Animal Disease Model[J]. .

References

1 王会会，陈国江，黎燕，等. 补体C5a、C5a受体及其拮抗剂的研究进展[J]. 国际药学研究杂志，2010，37(3)：181～186.
2 朱世明. C5a受体介导血管渗透性的机制[D]. 武汉：湖北大学，2010.
3 宋蓉，陈月，吕凤林，等. C5L2不再是孤儿受体——进展与展望[J]. 免疫学杂志，2007，23(2)：229～232.
4 陈月，吕凤林. 补体C5a新型抑制剂研究进展[J]. 中国免疫学杂志，2007，23(2)：180～184.
5 落智荣，帖菊霞，曹文斌，等. 念珠菌型小鼠乳房炎组织损伤程度与C3c补体激活水平相关性的研究[J]. 中国畜牧兽医，2007，34(1)：92～95.
6 Ager R, Fonseca M, Chu S, et al. Decreases in Alzheimer’s disease like pathology associated with C5aR inhibition correlate with improved performance in a passive avoidance task[J]. Molecular Immunology, 2008, 45(16): 4109.
7 Arumugam T V, Shiels I A, Woodruff T M, et al. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine[J]. Surgical Research, 2002, 103(2): 260～267.
8 Arumugam T V, Woodruff T M, Shelli Z, et al. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats[J]. Hepatology, 2004, 40(6): 934～941.
9 BeckK D, Nguyen H X, Galvan M D, et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: Evidence for amultiphasic inflammatory response in the acute to chronic environment[J]. Brain, 2010, 133(2): 433～447.
10 Blagg J, Mowbray C, Pryde D C, et al. Small, non-peptide C5a receptor antagonists: Part 1[J]. Bioorganic and Medicinal Chemistry Letters, 2008, 18(20): 5601～5604.
11 Boor P, Konieczny A, Villa L, et al. Complement C5 mediates experimental tubulointerstitial fibrosis[J]. American Society of Nephrology, 2007, 18(5): 1508～1515.
12 Brodbeck R M, Cortright D N, Kieltyka A P, et al. Identification and characterization of NDT 9513727[N, N-bis(1, 3-benzodioxol-5-ylmethyl)-1-butyl-2〖DK〗,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist[J]. Pharmacology and Experimental Therapeutics, 2008, 327(3): 898～909.
13 Bunschoten A, Ippel J H, Kruijtzer J A, et al. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: Towards the development of novel anti-inflammatory compounds[J]. Amino Acids, 2011, 40(2): 731～740.
14 Garrett M C, Otten M L, Starke R M, et al. Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage[J]. Brain Research, 2009, 1298: 171～177.
15 Hezmee M N, Kyaw-Tanner M, Lee J Y, et al. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors[J]. Veterinary Immunology and Immunopathology, 2011, 139(1): 50～56.
16 Hezmee M N, Shiels I A, Rolfe B E, et al. Complement C5a: Impact on the field of veterinary medicine[J]. Veterinary, 2012, 192(3): 264～271.
17 Huber-Lang M S, Riedeman N C, Sarma J V, et al. Protection of innate immunity by C5aR antagonist in septic mice[J]. FASEB, 2002, 16(12): 1567～1574.
18 Li K, Choudhry N, Peng Q, et al. C5a-C5aR interaction promotes kidney infection through acting on both renal and circulating cells[J]. Immunobiology, 2012, 217(11): 1145.
19 Li R, Coulthard L G, Wu M C. C5L2: A controversial receptor of complement anaphylatoxin, C5a[J]. FASEB, 2013, 27(3): 855～864.
20 Liang D Y, Li X Q, Shi X Y, et al. The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model[J]. Pain, 2012, 153(2): 366～372.
21 Manthey H D, Thomas A C, Shiels I A, et al. Complement C5a inhibition reduces atherosclerosis in ApoE-/-mice[J]. FASEB Journal, 2011, 25(7): 2447～2455.
22 Peng Q, Li K, Wang N, et al. Dendritic cell function in allostimulation is modulated by C5aR signaling[J]. Immunology, 2009, 183(10): 6058～6068.
23 Peng Q, Xing G, Li K, et al. Double deficiency of C5aR/C3aR significantly prevents mice from renal ischemia/reperfusion injury[J]. Molecular Immunology, 2010, 47(13): 2235.
24 Qu H C, Ricklin D, Lambris J D. Recent developments in low molecular weight complement inhibitors[J]. Molecular Immunology, 2009, 47(2～3): 185～195.
25 Riley R D, Sato H, Zhao Z Q, et al. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization[J]. Thoracic and Cardiovascular Surgery, 2000, 120(2): 350～358.
26 Schmudde I, Laumonnier Y, Strver H A, et al. C5a receptor signalling in dendritic cells regulates the development of maladaptive Th2 and Th17 immune responses in experimental allergic asthma[J]. Immunobiology, 2012, 217(11): 1145.
27 Schnatbaum K, Locardi E, Scharn D. Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: Increased receptor specificity and in vivo activity[J]. Bioorganic and Medicinal Chemistry Letters, 2006, 16(19): 5088～5092.
28 Shagdarsuren E, Bidzhekov K, Mause S F, et al. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice[J]. Circulation, 2010, 122(10): 1026～1036.
29 van der Pals J, Koul S, Andersson P, et al. Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model[J]. BMC Cardiovascular Disorders, 2010, 10: 45.
30 Waters S M, Brodbeck R M, Steflik J, et al. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction[J]. Biological Chemistry, 2005, 280(12): 40617～40623.
31 Woodruff T M, Strachan A J, Sanderson S D, et al. Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes[J]. Inflammation, 2001, 25(3): 171～177.
32 Woodruff T M, Strachan A J, Dryburgh N, et al. Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat[J]. Arthritis and Rheumatism, 2002, 46(9): 2476～2485.
33 Woodruff T M, Arumugam T V, Shiels I A. Protective effects of a potent C5a receptor antagonist on experimental acute lmb ischemia-reperfusion in rats[J]. Surgical Research, 2004, 116(1): 81～90.
34 Woodruff T M, Pollitt S, Proctor L M, et al. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease[J]. Pharmacology and Experiment Therapeutics, 2005, 314(2): 811～817.
35 Woodruff T M, Ager R R, Tenner A J, et al. The role of the complement system and the activation fragment C5a in the central nervous system[J]. Neuromolecular Medicine, 2010, 12(2): 179～192.
36 Woodruff T M, Nandakumar K S, Tedesco F. Inhibiting the C5-C5a receptor axis[J]. Molecular Immunology, 2011, 48(14): 1631～1642.
37 Xiao H, Jennette J C, Dairaghi D, et al. Robust efficacy of C5aR antagonist CCX168 in a mouse model of ANCA glomerulonephritis[J]. American Society of Nephrology, 2010, 21: 40.

[1]	YANG Zhi, YU Jiaxin, YANG Linfu, WANG Kang, LI Guanzong, DUAN Gang, YANG Fumei, LIU Zhiqi, ZHOU Ke, HE Jun, DAI Feiyan. Study on the Therapeutic Effect of Modified Sini Decoction on Piglet Diarrhea [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(4): 1707-1717.
[2]	LI Min, ZHAO Zunfu, YANG Tingting, ZHANG Huanrong. Prevention and Treatment Effect of Escherichia coli Phage BP16 on Chicken Colibacillosis [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(2): 776-782.
[3]	JIAO Ying, JI Lingxi, HUANG Wei, XIAO Meng, LYU Yanli. Diagnosis and Treatment of Feline Dermatophytic Pseudomycetoma [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(3): 1141-1147.
[4]	WANG Antian, HUANG Jing, SUN Yufan, SONG Bingxiao, TAN Chen, HUANG Qi, ZHOU Rui, LI Lu. Antibacterial Activity of Porcine Beta Defensin-2 Against Porcine Extraintestinal Pathogenic Escherichia coli in vivo and in vitro [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(2): 726-735.
[5]	XU Xi, YANG Sha, HAO Haisheng, DU Weihua, PANG Yunwei, ZHAO Shanjiang, ZOU Huiying, ZHU Huabin, LI Shujing, YU Wenli, ZHAO Xueming. Research Progress on Application of Single Base Editing Technology [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(12): 4403-4411.
[6]	BAI Weiqin, LI Hong, MENG Ke, ZI Zhanfei, LI Jie, ZHAO Lijun, WANG Jinling, GE Riletu, LI Qi, JI Lintai. Isolation and Identification of a Pathogenic Enterococcus faecium from Sheep [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(10): 3889-3895.
[7]	ZHENG Jian, YANG Jinshan, FANG Xinpeng, ZHAO Hongbo, ZHANG Yonggen. The Optimization of Ultrasonic to Improve the Fiber Structure of Ammoniated Rice Straw and Its Effect on Rumen Degradation Characteristics [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(7): 2033-2042.
[8]	TAN Shumin, ZHOU Jizhang. Research Progress on Vaccine Immunization and Treatment of Animal Chlamydiosis [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(5): 1539-1546.
[9]	REN Xiaoli, FAN Yuying, JIN Shuangxing, ZHANG Lei, LIU Yun, SHI Dongmei. Research Progress on Oncolytic Viruses in Canine Tumor Treatment [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(3): 965-971.
[10]	QIN Feng, LIU Yun, WU Zhi, FENG Qi, WU Shuang, SONG Haigang, WU Xiaojie, ZHU Shanyuan. Study on the Prevention and Control Effect of Chinese Herbal Compound on E.coli Infected Ducklings [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(10): 3371-3378.
[11]	HE Xiangbo, LI Ying, XU Jincong, MIAO Jing, GAN Qianfu, LIANG Xuewu. Effect of Alkali Storage Treatments on Ruminal Nutrients Degradability of Spent Mushroom Substrate [J]. , 2019, 46(5): 1340-1352.
[12]	WANG Yuke, OU Yahong, ZHANG Liyun, WANG Yanxin, WANG Xu, PENG Dapeng, WANG Yulian, PAN Yuanhu, XIE Shuyu, CHEN Dongmei, HUANG Lingli, TAO Yanfei. Research Progress on Sample Preparation for Detection of Sulfonamides and Its Metabolites in Animal Food and Environment [J]. China Animal Husbandry and Veterinary Medicine, 2019, 46(10): 3032-3041.
[13]	XU Hongjian, ZHANG Liyang, LIU Xin, JIANG Xin, LI Xin, ZHANG Yonggen. Study on the Correlation Between the CNCPS Fractions and Furosine Content in DDGS with Different Heat Treatment [J]. , 2018, 45(12): 3471-3478.
[14]	ZHENG Xinxin, LI Fukuan, PAN Zhangyuan, LV Shenjin, WANG Hui. Research Progress on Pharmacological Action of Astragalus Polysaccharide and Its Application in Piglet Disease Prevention and Treatment [J]. , 2018, 45(10): 2918-2926.
[15]	YANG Xia, ZHANG Dian-qing, SONG Jia-wei, XIAO Sheng-zhong, SHENG Jin-liang, YAN Gen-qiang. Antimicrobial Activity of Synthesized Sheep NK-Lysin Peptides and Its Treatment for Chicken Salmonella Challenge [J]. , 2017, 44(9): 2739-2746.

Research Progress on C5a Receptor Antagonists and their Treatment in Animal Disease Model

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments